Psychogenic stress-dependent disorders of menstrual cycle: role of non-hormonal correction
Keywords:stress, adaptation, menstrual cycle disorders, oligomenorrhea, transient hyperprolactinemia, Vitex agnus-castus
Menstrual disorders are widespread in the population, a significant part of them is associated with stress. However, stress is not identical simply to nervous tension, it is a nonspecific reaction to changes in conditions that require adaptation. Stress factors should be divided into physical, metabolic and psychological factors. Of particular importance are violations
of the biological rhythms of the body, as well as psychological features of the relationship of patients with the mother. In general, with expressed stress, the reproductive function is inhibited. This effect is realized in several ways, in particular through transient hyperprolactinemia. Treatment of functional, stress-dependent hyperprolactinemia is carried out by plant dopaminomimetics. The use of Vitex agnus-castus drugs in such patients normalizes the secretion of prolactin and regulates the menstrual cycle
- Adilkhanova, A.H. “Medico-social preconditions for the development of the reproductive system in adolescent girls from disadvantaged families.” Thesis abstract for PhD degree. St. Petersburg (2011).
- Gorelyshev, A., Kuznetsova, I.“Menstrual cycle and energy «policy» of the hypothalamus.” Effective pharmacotherapy 5 (2015): 4–12.
- Filippova, G. “Violations of the reproductive function and its connection with disturbances in the formation of the maternal sphere.” Journal of Practical Psychologist 4–5 (2003): 83–109.
- Kubasov, R. “Functional changes in pituitary-gonadal and thyroid endocrine parts in response to stress factors.” Fundamental researches 10 (2014): 1010–4.
- Tworoger, S.S., Eliassen, A.H., Zhang, X., et al. “A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development.” Cancer Res 73 (2013): 4810–9. DOI: 10.1158/0008–5472.CAN-13–0665
- McHale, K., Tomaszewski, J.E., Puthiyaveettil, R., et al. “Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma.” Mod Pathol 21 (2008): 565–71. DOI: 10.1038/modpathol.2008.7
- Freeman, E.W. “Therapeutic management of premenstrual syndrome.” Expert Opin Pharmacother 11 (2010): 2879–89. DOI: 10.1517/14656566.2010.509344
- Biason, T.P., Goldberg, T.B.L., Kurokawa, C.S., et al. “Low-dose combined oral contraceptive use is associated with lower bone mineral content variation in adolescents over a 1-year period.” BMC Endocr Disord 15 (2015): 15. DOI: 10.1186/s12902–015–0012–7
- Simonovskaya, H. “Phytotherapy: green perspectives. Interview with the chairman of the board of directors «Bionorica» company, prof. Michael Popp.” Status Praesens 5 (2012): 39–45.
- Wuttke, W., Seidlova-Wuttke, D., Jarry, H., Artymuk, N. “The role of Vitex sacred (Vitex agnus castus) in gynecological endocrinology.” Gynecology 1 (2014): 4–7.
- Wuttke, W., Seidlova-Wuttke, D., Jarry, H., Artymuk, N. “Der Stelenwert des Monchspfeffer (Vitex agnus-castus).” Zeitschrift Fur Phyther 31 (2010): 294–8.
- Artymuk, N., Ustinova, T., Vlasova, V. “Experience of application of Vitex Agnus Castus in the complex of treatment of patients with polycystic ovary syndrome and infertility.” Russian bulletin of obstetrician-gynecologist 2 (2011): 65–8.
- Tsoy, L. “Drug therapy of diffuse mastopathy and PMS.” Oncology, hematology and radiology 3 (2010): 2–7.
- Elsayed, M. “Agnucaston and Clomiphen Citrate in Infertile Patients with Polycystic Ovaries.” J Fertil Vitr. IVF-Worldwide, Reprod Med Genitics Stem Cell Biol 2 (2013): 33–40. DOI: 10.4172/2375–4508.1000108
- Khalilzadeh, E., Vafaei Saiah, G., Hasannejad, H., et al. “Antinociceptive effects, acute toxicity and chemical composition of Vitex agnus-castus essential oil.” Avicenna J Phytomed 5.3 (2015): 218–30.
- Ma, L., Lin, S., Chen, R., et al. “Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women.” Aust New Zeal J Obstet Gynaecol 50 (2010): 189–93. DOI: 10.1111/j.1479–828X.2010.01137.x.
- Zamani, M., Neghab, N., Torabian, S. “Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome.” Acta Med Iran 50 (2012): 101–6.
- van Die, M., Burger, H., Teede, H., Bone, K. “Vitex agnus-castus Extracts for Female Reproductive Disorders: A Systematic Review of Clinical Trials.” Planta Med 79 (2012): 562–75. DOI: 10.1055/s-0032–1327831
- Arentz, S., Abbott, J.A., Smith, C.A., Bensoussan, A. “Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.” BMC Complement Altern Med 14 (2014): 511. DOI: 10.1186/1472–6882–14–511
- Shahin, A.Y., Mohammed, S.A. “Adding the phytoestrogen Cimicifugae Racemosae to clomiphene induction cycles with timed intercourse in polycystic ovary syndrome improves cycle outcomes and pregnancy rates – a randomized trial.” Gynecol Endocrinol 30 (2014): 505–10. DOI: 10.3109/09513590.2014.895983
- Kamel, H.H. “Role of phyto-oestrogens in ovulation induction in women with polycystic ovarian syndrome.” Eur J Obstet Gynecol Reprod Biol 168 (2013): 60–3. DOI: 10.1016/j.ejogrb.2012.12.025
- Kuznetsova, I., Uspenskaya, Y., Dil, V., Grineva, A. “Use of vegetable dopaminomimetic in adolescents and young women with a disturbed menstrual cycle.” Obstetrics and Gynecology 10 (2015): 1–8.
How to Cite
Copyright (c) 2018 И. В. Кузнецова, М. Н. Бурчакова, Д. И. Бурчаков, Н. Х. Хаджиева, Г. Г. Филиппова
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.